Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, has moved its global corporate headquarters from Waltham, MA to Burlington, MA. The significantly larger office space located at 8 New England Executive Park in Burlington, MA allows the Company to plan for future growth.
Decision Resources, Inc., which currently is comprised of seven unique company brands including Arlington Medial Resources, BioTrends Research Group, Decision Resources, Fingertip Formulary, HealthLeaders-InterStudy, Manhattan Research Group and Millennium Research Group, plans both organic growth and expansion through more acquisitions.
"Moving our global corporate headquarters to a larger, more sophisticated office park allows us to upgrade many business services to properly manage the exponential growth of Decision Resources, Inc.," said Peter Hoenigsberg, CEO of Decision Resources, Inc. "Our growth strategy continues to center around the guiding principle of offering innovative market research and high-value analytics to the healthcare industry. We look forward to expanding our premium offerings in the new enhanced business environment that 8 New England Executive Park offers."
FHO Partners represented Decision Resources, Inc. in its search, selection and negotiation of 8 New England Executive Park which is managed by Equity Office Properties.
Decision Resources, Inc. was also named to this year's Inc. 5000 list making it the third year in a row the Company has been ranked.
Radnet’s DeepHealth and HOPPR forge partnership to advance AI in healthcare